Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-01 Sale | 2024-04-03 8:47 pm | Terns Pharmaceuticals Inc. | TERN | Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner | 420,663 | $6.6487 | $2,796,859 | 268,573 (Indirect) | View |
| 2023-11-30 Purchase | 2023-12-04 6:03 pm | Terns Pharmaceuticals Inc. | TERN | Yoon Seokho Bryan COO and General Counsel | 743 | $3.78 | $2,809 | 18,399 (Direct) | View |
| 2023-11-30 Purchase | 2023-12-04 6:03 pm | Terns Pharmaceuticals Inc. | TERN | Vignola Mark J. Chief Financial Officer | 743 | $3.78 | $2,809 | 18,399 (Direct) | View |
| 2023-05-31 Purchase | 2023-06-02 5:03 pm | Terns Pharmaceuticals Inc. | TERN | Vignola Mark J. Chief Financial Officer | 9,997 | $1.41 | $14,096 | 17,656 (Direct) | View |
| 2023-05-31 Purchase | 2023-06-02 5:03 pm | Terns Pharmaceuticals Inc. | TERN | Yoon Seokho Bryan COO and General Counsel | 9,997 | $1.41 | $14,096 | 17,656 (Direct) | View |
| 2023-05-31 Purchase | 2023-06-02 5:03 pm | Terns Pharmaceuticals Inc. | TERN | Sundaram Senthil Vel Chief Executive Officer | 2,111 | $1.41 | $2,977 | 9,770 (Direct) | View |
| 2022-11-30 Purchase | 2023-02-03 6:01 pm | Terns Pharmaceuticals Inc. | TERN | Yoon Seokho Bryan COO and General Counsel | 3 | $1.41 | $4 | 367,659 (Direct) | View |
| 2022-11-30 Purchase | 2023-02-03 6:01 pm | Terns Pharmaceuticals Inc. | TERN | Vignola Mark J. Chief Financial Officer | 3 | $1.41 | $4 | 367,659 (Direct) | View |
| 2022-11-30 Purchase | 2023-02-03 6:00 pm | Terns Pharmaceuticals Inc. | TERN | Sundaram Senthil Vel Chief Executive Officer | 3 | $1.41 | $4 | 907,659 (Direct) | View |
| 2022-12-23 Purchase | 2022-12-28 5:57 pm | Terns Pharmaceuticals Inc. | TERN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Asia GP III L.P. OrbiMed Advisors III Ltd OrbiMed Genesis GP LLC Director 10% Owner | 137,931 | $7.25 | $1,000,000 | 7,619,135 (Indirect) | View |
| 2022-12-23 Purchase | 2022-12-28 5:46 pm | Terns Pharmaceuticals Inc. | TERN | GORDON CARL L Director 10% Owner | 137,931 | $7.25 | $1,000,000 | 7,619,135 (Indirect) | View |
| 2022-12-23 Purchase | 2022-12-23 5:48 pm | Terns Pharmaceuticals Inc. | TERN | Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner | 758,620 | $7.25 | $5,499,995 | 6,657,992 (Indirect) | View |
| 2022-12-23 Purchase | 2022-12-23 5:44 pm | Terns Pharmaceuticals Inc. | TERN | Lu Hongbo Director | 758,620 | $7.25 | $5,499,995 | 4,340,212 (Indirect) | View |
| 2022-11-23 Sale | 2022-11-28 4:56 pm | Terns Pharmaceuticals Inc. | TERN | LAV Biosciences Fund V L.P. Hopewell Resources Holdings Ltd LAV Aqua Ltd Oriental Spring Venture Ltd 10% Owner | 1,500,000 | $5.5 | $8,250,000 | 1,816,460 (Indirect) | View |
| 2022-09-07 Purchase | 2022-09-08 8:00 pm | Terns Pharmaceuticals Inc. | TERN | Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner | 600,000 | $3.6 | $2,160,000 | 5,899,372 (Indirect) | View |
| 2022-09-07 Purchase | 2022-09-08 8:00 pm | Terns Pharmaceuticals Inc. | TERN | Lu Hongbo Director | 600,000 | $3.6 | $2,160,000 | 3,581,592 (Indirect) | View |
| 2022-08-16 Purchase | 2022-08-18 5:00 pm | Terns Pharmaceuticals Inc. | TERN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Asia GP III L.P. OrbiMed Advisors III Ltd OrbiMed Genesis GP LLC Director 10% Owner | 3,690,000 | $2.42 | $8,929,800 | 1,072,400 (Indirect) | View |
| 2022-08-16 Purchase | 2022-08-18 4:50 pm | Terns Pharmaceuticals Inc. | TERN | GORDON CARL L Director 10% Owner | 3,690,000 | $2.42 | $8,929,800 | 1,072,400 (Indirect) | View |
| 2022-08-12 Purchase | 2022-08-16 8:44 pm | Terns Pharmaceuticals Inc. | TERN | Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner | 2,624,239 | $2.6599 | $6,980,244 | 6,799,372 (Indirect) | View |
| 2022-08-12 Purchase | 2022-08-16 8:30 pm | Terns Pharmaceuticals Inc. | TERN | Lu Hongbo Director | 2,624,239 | $2.6599 | $6,980,244 | 4,481,592 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-03-19 7:26 pm | N/A N/A | Terns Pharmaceuticals Inc. | TERN | Kuriakose Emil Chief Medical Officer | 0 | $0 | 456,250 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 6:01 pm | N/A N/A | Terns Pharmaceuticals Inc. | TERN | Burroughs Amy L. Chief Executive Officer | 1,400,000 | $0 | 1,400,000 (Direct) | View |
| 2024-01-23 Option Award | 2024-01-25 7:18 pm | N/A N/A | Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Sr. Advisor & Strategy Officer | 15,000 | $0 | 30,000 (Direct) | View |
| 2024-01-23 Option Award | 2024-01-25 7:18 pm | N/A 2034-01-22 | Terns Pharmaceuticals Inc. | TERN | Yoon Seokho Bryan COO and General Counsel | 206,250 | $0 | 224,649 (Direct) | View |
| 2024-01-23 Option Award | 2024-01-25 7:17 pm | N/A 2034-01-22 | Terns Pharmaceuticals Inc. | TERN | Vignola Mark J. Chief Financial Officer | 206,250 | $0 | 224,649 (Direct) | View |
| 2024-01-23 Option Award | 2024-01-25 7:17 pm | N/A 2034-01-22 | Terns Pharmaceuticals Inc. | TERN | Quirk Erin President, Head of R&D | 225,000 | $0 | 225,000 (Direct) | View |
| 2023-11-15 Option Award | 2023-11-17 6:10 pm | N/A N/A | Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Sr. Advisor & Strategy Officer | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-06-12 Option Award | 2023-06-14 7:02 pm | N/A 2033-06-11 | Terns Pharmaceuticals Inc. | TERN | Taylor Ann Elizabeth Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2023-06-12 Option Award | 2023-06-14 7:02 pm | N/A 2033-06-11 | Terns Pharmaceuticals Inc. | TERN | Tripuraneni Radhika Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2023-06-12 Option Award | 2023-06-14 7:02 pm | N/A 2033-06-11 | Terns Pharmaceuticals Inc. | TERN | Quigley Jill M. Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2023-06-12 Option Award | 2023-06-14 7:01 pm | N/A 2033-06-11 | Terns Pharmaceuticals Inc. | TERN | FELLOWS DAVID A Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2023-06-12 Option Award | 2023-06-14 7:01 pm | N/A 2033-06-11 | Terns Pharmaceuticals Inc. | TERN | GORDON CARL L Director 10% Owner | 32,000 | $0 | 32,000 (Direct) | View |
| 2023-06-12 Option Award | 2023-06-14 7:01 pm | N/A 2033-06-11 | Terns Pharmaceuticals Inc. | TERN | Lu Hongbo Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2023-06-12 Option Award | 2023-06-14 7:01 pm | N/A 2033-06-11 | Terns Pharmaceuticals Inc. | TERN | KINDLER JEFFREY B Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 6:01 pm | N/A 2033-01-31 | Terns Pharmaceuticals Inc. | TERN | Yoon Seokho Bryan COO and General Counsel | 360,000 | $0 | 367,659 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 6:01 pm | N/A 2033-01-31 | Terns Pharmaceuticals Inc. | TERN | Vignola Mark J. Chief Financial Officer | 360,000 | $0 | 367,659 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 6:00 pm | N/A 2033-01-31 | Terns Pharmaceuticals Inc. | TERN | Quirk Erin President, Head of R&D | 600,000 | $0 | 600,000 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 6:00 pm | N/A 2033-01-31 | Terns Pharmaceuticals Inc. | TERN | Sundaram Senthil Vel Chief Executive Officer | 900,000 | $0 | 907,659 (Direct) | View |
| 2022-07-26 Option Award | 2022-07-28 8:08 pm | N/A 2032-07-25 | Terns Pharmaceuticals Inc. | TERN | Tripuraneni Radhika Director | 64,000 | $0 | 64,000 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-06 8:07 pm | N/A 2032-06-30 | Terns Pharmaceuticals Inc. | TERN | Russell Kerry Strong Chief Medical Officer | 240,000 | $0 | 240,000 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-21 9:00 pm | N/A 2032-06-15 | Terns Pharmaceuticals Inc. | TERN | Taylor Ann Elizabeth Director | 32,000 | $0 | 32,000 (Direct) | View |